Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Experimental and clinical endocrinology & diabetes

• Publication date

  2009-07-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/S-0029-1211418PMID 8750567
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of the Insulin Analogue [LYS(B28),PRO(B29)] on Blood Glucose Control

  1994cited by this paper
• Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM

  1994cited by this paper
• [Lys(B28), Pro(B29)]-Human Insulin: A Rapidly Absorbed Analogue of Human Insulin

  1994cited by this paper
• Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia.

  1993cited by this paper
• New Directions in Drug Development: Mixtures, Analogues, and Modeling

  1993cited by this paper
• Reduced Neuroendocrine and Symptomatic Responses to Subsequent Hypoglycemia After 1 Episode of Hypoglycemia in Nondiabetic Humans

  1991cited by this paper
• Monomeric Insulins and Their Experimental and Clinical Implications

  1990cited by this paper
• The pharmacokinetic basis of insulin therapy in diabetes mellitus.

  1989cited by this paper
• Physiological Importance of Deficiency in Early Prandial Insulin Secretion in Non-Insulin-Dependent Diabetes

  1988cited by this paper
• Effect of Intensive Insulin Therapy on Glycemic Thresholds for Counterregulatory Hormone Release

  1988cited by this paper
• Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus.

  1984cited by this paper
• Insulin Pharmacokinetics

  1984cited by this paper
• Algorithms for Adjustment of Insulin Dosage by Patients Who Monitor Blood Glucose

  1981cited by this paper
• The use of non-parametric methods in the statistical analysis of the two-period change-over design.

  1972cited by this paper

• Guía de práctica clínica sobre Diabetes Mellitus Tipo 1

  2026cites this paper
• Prandial Insulins: A Person-Centered Choice

  2024cites this paper
• Comparison of Insulin Analogs and Human Insulins: A Narrative Review

  2023cites this paper
• [One hundred years after the discovery of insulin: a new revolution for patients living with type 1 diabetes?]

  2022cites this paper
• Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review

  2020cites this paper
• Efficacy and Safety of Intramuscular Insulin Lispro vs. Continuous Intravenous Regular Insulin for the Treatment of Dogs With Diabetic Ketoacidosis

  2020cites this paper
• Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes

  2019cites this paper
• Pharmacodynamics and pharmacokinetics of insulin aspart assessed by use of the isoglycemic clamp method in healthy cats.

  2018cites this paper
• A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus

  2018cites this paper
• Comparison of quality of life in a group of Lebanese type 1 diabetics on insulin pump and those on multiple daily injections.

  2014influential citation
• The Barmer study: impact of standardized warming of the injection site to enhance insulin absorption and reduce prandial insulin requirements and hypoglycemia in obese patients with diabetes mellitus

  2014cites this paper
• Insulin Analogs—Is There a Compelling Case to Use Them? No!

  2014cites this paper
• 6. Diabetes Drugs

  2013cites this paper
• Cumulative clinical experience with use of insulin lispro: critical appraisal, role in therapy, and patient considerations

  2012cites this paper
• A New Era in Diabetic Agents: Hope for Diabetics

  2012cites this paper
• Review of Insulin and its Analogues in Diabetes Mellitus

  2012cites this paper
• Insulin Lispro

  2012cites this paper
• Rapid-acting insulin analogues in Basal-bolus regimens in type 1 diabetes mellitus.

  2010cites this paper
• Type 1 Diabetes in Adults

  2010cites this paper
• Impact of Intensive Therapy With Continuous Subcutaneous Insulin Infusion on Quality of Life in Patients With Type 1 Diabetes

  2010cites this paper
• Insulin analogues: an example of applied medical science

  2009cites this paper
• Frequency of severe hypoglycaemia in type 1 and type 2 diabetes during conventional insulin therapy.

  2009cites this paper
• Exploring The Quality-Of-Life Benefits With Insulin Analog Use

  2009influential citation
• Use of Short Acting Modern Insulins in Special Situation

  2009cites this paper
• An estimation of the long-term clinical and economic benefits of insulin lispro in Type 1 diabetes in the UK

  2009cites this paper
• Cessation of insulin infusion at night-time during CSII-therapy: comparison of regular human insulin and insulin lispro.

  2009cites this paper
• Rapid Acting Analogues in Diabetes Mellitus Management

  2009cites this paper
• Hypoglycemia in Type 1 Diabetes

  2008cites this paper
• Insulin analogues: Action profiles beyond glycaemic control

  2008cites this paper
• Rapid Acting Analogues in Diabetes Mellitus Management 225 40 Rapid Acting Analogues in Diabetes Mellitus Management

  2007cites this paper
• American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus.

  2007cites this paper
• Why and How to Use Insulin Therapy Earlier in the Management of Type 2 Diabetes

  2007cites this paper
• A review of human and analogue insulin trials.

  2007cites this paper
• The potential for the use of insulin lispro in pregnancy complicated by diabetes

  2006cites this paper
• Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.

  2006cites this paper
• Optimal insulin treatment for patients with type 2 diabetes Basal or prandial insulin supplementation

  2006cites this paper
• Type 1 Diabetes in Children, Adolescents, and Young Adults: How to Become an Expert on Your Own Diabetes

  2006cites this paper
• Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.

  2006cites this paper
• Comparison of Costs and Utilization Between Users of Insulin Lispro Versus Users of Regular Insulin in a Managed Care Setting

  2005cites this paper
• Insulin analogues.

  2005cites this paper
• Les nouvelles insulines

  2005cites this paper
• Review of Insulin Therapy

  2004cites this paper
• Management of diabetes and hyperglycemia in hospitals.

  2004cites this paper
• Meta-analysis of short-acting insulin analogues in adult patients with type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapy

  2004cites this paper
• Use of the rapid acting insulin analogue lispro and its protamine retarded form (Humalog Mix 25) in a clinical setting

  2004cites this paper
• Hypoglycaemia with insulin aspart: a double‐blind, randomised, crossover trial in subjects with Type 1 diabetes

  2004cites this paper
• Insulin analogues in the management of diabetes.

  2004cites this paper
• Common problems in outpatient management of patients with diabetes in the age of insulin analogues.

  2003cites this paper
• Effect of long-term exposure to insulin lispro on the induction of antibody response in patients with type 1 or type 2 diabetes.

  2003cites this paper
• Hypoglycemia Warning Signal and Glucose Sensors: Requirements and Concepts

  2003cites this paper
• Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review.

  2003cites this paper
• Insulin lispro: a useful advance in insulin therapy

  2003cites this paper
• Inhaled insulin using the AERx Insulin Diabetes Management System in healthy and asthmatic subjects.

  2003cites this paper
• Management of Diabetes: New Aspects of Insulin Therapy in Type 1 and Type 2 Diabetes

  2002cites this paper
• Assessment of therapy with continuous subcutaneous insulin infusion in an academic diabetes clinic.

  2002cites this paper
• Novel insulins: expanding options in diabetes management.

  2002cites this paper
• Nocturnal hypoglycemia detected with the Continuous Glucose Monitoring System in pediatric patients with type 1 diabetes.

  2002cites this paper
• Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents.

  2002cites this paper
• Efficacy of Humalog® injections before an afternoon meal and their acceptance by children and adolescents with Type 1 diabetes

  2002cites this paper
• A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents.

  2001cites this paper
• Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection.

  2001cites this paper
• Management of Diabetes Mellitus

  2001cites this paper
• Recombinant DNA technology in the treatment of diabetes: insulin analogs.

  2001cites this paper
• Management of Diabetes Mellitus Defining the Role of Insulin Lispro Mix75/25 (Humalog ® Mix75/25™)

  2001cites this paper
• Intensive diabetes management in pediatric patients

  2001cites this paper
• Revisão da hiperglicemia pós-prandial e a hipoglicemia no controle do diabetes mellitus: o papel da insulina lispro e suas pré-misturas nos picos e vales

  2001cites this paper
• Severe hypoglycaemia in patients with type 1 diabetes and impaired awareness of hypoglycaemia: a comparative study of insulin lispro and regular human insulin

  2001cites this paper
• New aspects of insulin therapy in type 1 and type 2 diabetes

  2001cites this paper
• The use of lispro for high sugar content snacks between meals in intensive insulin regimens

  2000cites this paper
• The Economic Value of a New Insulin Preparation, Humalog® Mix 25™

  2000cites this paper
• Menor incidência de hipoglicemia noturna com o uso de insulina lispro comparada à insulina humana regular no tratamento de pacientes com diabetes do tipo 1

  2000cites this paper
• [Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus].

  2000cites this paper
• Genetically engineered insulin analogs: diabetes in the new millenium.

  2000cites this paper
• Insulin analogues and their potential in the management of diabetes mellitus

  1999cites this paper
• Pharmacological management of diabetes: recent progress and future perspective in daily drug treatment.

  1999cites this paper
• Hypoglycemia and insulin analogues: is there a reduction in the incidence?

  1999cites this paper
• Hypoglycaemia in children and adolescents with Type 1 diabetes mellitus.

  1999cites this paper
• Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group.

  1999cites this paper
• Use of Insulin Lispro in Continuous Subcutaneous Insulin Infusion Tre a t m e n t

  1999cites this paper
• Insulin Lispro: A critical evaluation

  1999cites this paper
• Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.

  1999cites this paper
• Use of Lispro Insulin and Quality of Life in Adolescents on Intensive Therapy

  1999cites this paper
• Insulin analogs with improved pharmacokinetic profiles.

  1999cites this paper
• Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group.

  1999cites this paper
• Insulin lispro: experience in a private practice setting

  1999cites this paper
• Safety of insulin lispro: pooled data from clinical trials.

  1999cites this paper
• What is the role of between meal snacks with intensive basal bolus regimens using preprandial lispro?

  1999cites this paper
• Comparison of metabolic deterioration between insulin analog and regular insulin after a 5-hour interruption of a continuous subcutaneous insulin infusion in type 1 diabetic patients.

  1999cites this paper
• Insulin lispro in the treatment of patients with type 2 diabetes mellitus after oral agent failure.

  1999cites this paper
• Insulin Lispro, a New Insulin Analog

  1998cites this paper
• Improvement of HbA1c and Blood Glucose Stability in IDDM Patients Treated With Lispro Insulin Analog in External Pumps

  1998cites this paper
• Counterregulatory Hormone Responses After Long-Term Continuous Subcutaneous Insulin Infusion With Lispro Insulin

  1998cites this paper
• Reducing snacks when switching from conventional soluble to lispro insulin treatment: effects on glycaemic control and hypoglycaemia

  1998cites this paper
• Use of the short‐acting insulin analogue lispro in intensive treatment of Type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time‐interval injection‐meal

  1998cites this paper
• Guidelines for using insulin lispro.

  1998cites this paper
• Recombinant Human Insulin Analogues

  1998cites this paper
• Insulin lispro (Humalog), the first marketed insulin analogue: indications, contraindications and need for further study.

  1998cites this paper
• Postprandial Insulin Lispro: A new therapeutic option for type 1 diabetic patients

  1998cites this paper
• Meta-Analysis of the Effect of Insulin Lispro on Severe Hypoglycemia in Patients With Type 1 Diabetes

  1998cites this paper
• 1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association.

  1998cites this paper